# 18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study

> **NCT05707182** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 18F-rhPSMA-7.3

## Key facts

- **NCT ID:** NCT05707182
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-04-30
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Recruitment was difficult.
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05707182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05707182, "18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05707182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*